About Indu Pharma Private Limited
Data last updated:
Indu Pharma Private Limited was a private limited company based in Hyderabad, Andhra Pradesh, India, operated as a subsidiary of Ra Chem Pharma Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 August 2004.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC043904. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Cr and a paid-up capital of ₹81 Lakh. It was led by directors including Sirish Kumar Ravula and Ravi Kumar Yerra.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Plot No.26 & 27 Technorats Industrial Estate Balanagar Hyderabad – 37., Andhra Pradesh, India – 500037.
As per the financials filed for FY 2019, the company reported a revenue of ₹13.1 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹2.18 Lakh (net margin -16.6%) and EBITDA of ₹12.41 Lakh (EBITDA margin 94.8%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 2% over five years.
As per MCA filings, the company had satisfied charges of ₹81.34 Cr on record.
The last known website on record is rachempharma.com.
CIN History of Indu Pharma Private Limited
Indu Pharma has one previous CIN (Corporate Identification Number): U24239AP2004PTC043904. The current CIN is U24239TG2004PTC043904, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC043904 | Current |
| U24239AP2004PTC043904 | Previous |
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.26 & 27 Technorats Industrial Estate Balanagar Hyderabad – 37., Andhra Pradesh, India – 500037
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Indu Pharma Private Limited
The main business activity of Indu Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Indu Pharma Private Limited FY 2019 filings available
Indu Pharma Private Limited reported revenue of ₹13.1 Lakh (up 8% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR) of Indu Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 8% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Indu Pharma Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹13.1 Lakh | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12.41 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.18 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Indu Pharma Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 94.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -16.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Indu Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Indu Pharma Private Limited
Indu Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sirish Kumar Ravula Also directs: Devi Pharmatech Private Limited, Epione Labs Private Limited, Agil Seismic Services Private Limited and 3 more | Director | 02 Aug 2006 | 20 Years 2 Months | As last reported |
| Yogesh Shenoy Krishna | Additional Director | 28 Dec 2018 | 7 Years 9 Months | As last reported |
| Ravi Kumar Yerra Also directs: Devi Pharmatech Private Limited | Director | 01 Jun 2011 | 15 Years 4 Months | As last reported |
Peer Comparison of Indu Pharma Private Limited
Indu Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medmex Hospitality Private Limited | ₹13.17 Lakh (FY 2025) | •••• | •••• | -81.0% | •••• | Faridabad, Haryana, India |
| Sridhara Life Sciences Private Limited | ₹13.13 Lakh (FY 2021) | •••• | •••• | -98.0% | •••• | Indore, Madhya Pradesh, India |
| Kurkuma Health Sciences Private Limited | ₹13.12 Lakh (FY 2020) | •••• | •••• | •••• | Navi Mumbai, Maharashtra, India | |
| Delmas Pharmaceuticals Private Limited | ₹13.12 Lakh (FY 2024) | •••• | •••• | 13.0% | •••• | Jaipur, Rajasthan, India |
| Symchem Research Labs Private Limited | ₹13.11 Lakh (FY 2017) | •••• | •••• | -76.0% | •••• | Hyderabad, Telangana, India |
| Indu Pharma Private Limited this company | ₹13.1 Lakh (FY 2019) | •••• | •••• | 8.0% | •••• | Hyderabad, Andhra Pradesh, India |
| Regent Healthcare Limited | ₹13.09 Lakh (FY 2022) | •••• | •••• | -89.0% | •••• | Sahjanand Arcade, Helmet, Gujarat, India |
| Farm Gulp Private Limited | ₹13.05 Lakh (FY 2025) | •••• | •••• | 356.0% | •••• | Uttara Kannada, Karnataka, India |
| Enrico Scientific Private Limited | ₹13.02 Lakh (FY 2024) | •••• | •••• | -62.0% | •••• | Gurugram, Haryana, India |
| RMC Performance Chemicals Private Limited | ₹12.96 Lakh (FY 2024) | •••• | •••• | -21.0% | •••• | Jalgaon, Maharashtra, India |
| Valmicare Pharmaceuticals Private Limited | ₹12.91 Lakh (FY 2019) | •••• | •••• | -54.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Indu Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Indu Pharma Private Limited
Indu Pharma Private Limited is audited by CHAKRADHAR & NANDAN for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| CHAKRADHAR & NANDAN | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Indu Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Indu Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2013 | State Bank of India | ₹22.5 Cr | Satisfied |
| 27 Jun 2013 | State Bank of India | ₹22.5 Cr | Satisfied |
| 01 Oct 2010 | State Bank of India | ₹30.19 Cr | Satisfied |
| 17 Nov 2007 | State Bank of India | ₹4.25 Cr | Satisfied |
| 10 Nov 2004 | Canara Bank | ₹1.9 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Indu Pharma Private Limited
Employment history and EPFO contributions of people linked to Indu Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Indu Pharma Private Limited
Indu Pharma Private Limited has 5 board changes on record since 2006: 3 appointments and 2 cessations. The latest: Yogesh Shenoy Krishna was appointed as Additional Director on 28 Dec 2018.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Indu Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Indu Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Indu Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Indu Pharma Private Limited
Indu Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Indu Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Indu Pharma Private Limited
Frequently Asked Questions about Indu Pharma Private Limited
Indu Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Indu Pharma was a private limited company based in Hyderabad, Andhra Pradesh, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 16 August 2004 and is registered under CIN U24239TG2004PTC043904. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Indu Pharma was incorporated on 16 August 2004. It is registered with the Registrar of Companies, Hyderabad.
Indu Pharma had 3 directors:
- Sirish Kumar Ravula - Director
- Yogesh Shenoy Krishna - Additional Director
- Ravi Kumar Yerra - Director
The CIN (Corporate Identification Number) of Indu Pharma is U24239TG2004PTC043904. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Indu Pharma is at Plot No.26 & 27 Technorats Industrial Estate Balanagar Hyderabad – 37., Andhra Pradesh, India – 500037.
Indu Pharma can be reached through the website rachempharma.com. Its registered office is in Hyderabad, Andhra Pradesh, India.
Indu Pharma reported revenue of ₹13.1 Lakh for FY 2019 (up 8% YoY).
Indu Pharma has an authorised share capital of ₹1 Cr and a paid-up capital of ₹81 Lakh.
Indu Pharma reported a net loss of ₹2.18 Lakh (net margin -16.6%) and EBITDA of ₹12.41 Lakh (EBITDA margin 94.8%) for FY 2019, as per its filed financial statements.
No. Indu Pharma has 1 GST registration on record and it is cancelled or inactive.